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Long recognized to be potent suppressors of
immune responses, Foxp3+CD4+ regulatory T (Treg)
cells are being rediscovered as regulators of nonim-
munological processes. We describe a phenotypi-
cally and functionally distinct population of Treg cells
that rapidly accumulated in the acutely injured
skeletal muscle of mice, just as invading myeloid-
lineage cells switched from a proinflammatory to a
proregenerative state. A Treg population of similar
phenotype accumulated in muscles of genetically
dystrophic mice. Punctual depletion of Treg cells
during the repair process prolonged the proinflam-
matory infiltrate and impaired muscle repair, while
treatments that increased or decreased Treg activ-
ities diminished or enhanced (respectively) muscle
damage in a dystrophy model. Muscle Treg cells ex-
pressed the growth factor Amphiregulin, which acted
directly onmuscle satellite cells in vitro and improved
muscle repair in vivo. Thus, Treg cells and their prod-
ucts may provide new therapeutic opportunities for
wound repair and muscular dystrophies.
INTRODUCTION
Regulatory T (Treg) cells, particularly those of the Foxp3+CD4+
subset, are critical regulators of immune responses (Josefowicz
et al., 2012). They were originally described as controlling the
activities of other T cells but were later recognized to regulate
B cells and several innate immune system players. There have
also been recent reports of Treg cell control over nonimmunolog-
ical processes. Perhaps the best-characterized example is a
unique population of Treg cells residing in the visceral adipose
tissue (VAT) and regulating metabolic indices (Feuerer et al.,
2009; Cipolletta et al., 2011). The prevalence, transcriptome,
and T cell receptor (TCR) repertoire of this population are all
distinct from those of their counterparts in lymphoid organs.
Surveying a variety of tissues to see whether other nonimmuno-1282 Cell 155, 1282–1295, December 5, 2013 ª2013 Elsevier Inc.logical processes might be controlled by analogous Treg popu-
lations, our attention was drawn to a substantial accumulation of
Foxp3+CD4+ T cells in skeletal muscle undergoing repair after
acute injury.
Skeletal muscle regeneration follows the same orchestrated
plan regardless of the cause of muscle damage. It is driven
largely by satellite cells, a pool of quiescent precursors closely
associated with muscle fibers (Tabebordbar et al., 2013). In
response to injury, these cells become activated, proliferate,
differentiate, migrate, and fuse to form new myofibers. This
series of events is controlled by the sequential activation and
repression of specific transcription factors (Rudnicki et al.,
2008). With muscular dystrophies, in which chronic myofiber
loss occurs due to genetic defects, the satellite cell pool is called
on repeatedly, so it can exhaust or lose function over time,
dampening the repair process (Tabebordbar et al., 2013).
Regeneration of skeletal muscle is influenced by inflammatory
events that accompany repair (Tidball and Villalta, 2010).
Following an early, transient recruitment of neutrophils, myeloid
mononuclear cells, mainly derived from a pool of circulating
monocytes, infiltrate the injured tissue. Within days, the myeloid
infiltrate transitions from a pro- to an anti-inflammatory pheno-
type, a shift that is critical for proper muscle repair. An initial
population of proinflammatory, or M1-type, macrophages is
required for clearance of apoptotic or necrotic cells and deriva-
tive debris; a subsequent population of anti-inflammatory, or
M2-type, macrophages has various proregenerative functions,
such asmatrix remodeling and promotion of angiogenesis. Abla-
tion or impaired recruitment of macrophages severely compro-
mises muscle repair.
Though far less markedly, lymphocytes also accumulate in
skeletal muscle after acute injury, as well as in the dystrophin-
deficientmuscles ofmice harboring themdxmutation or humans
with Duchenne muscular dystrophy (DMD) (Tidball and Villalta,
2010). Their function has not been well studied, although both
CD4+ and CD8+ T cells seem to promote the mdx pathology.
Even less is known about the composition and function of infil-
trating T cell populations in models of acute muscle injury. In
particular, the contribution of Treg cells is yet to be addressed.
Here, we uncover a unique population of CD4+Foxp3+ Treg
cells that accumulates in skeletal muscle shortly after acute
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Figure 1. Treg Accumulation at the Site of Injury
(A–C) Cytofluorometric analyses of hindlimbmuscle infiltrates after Ctx injury. (A) Top: Ly6c expression byCD11b+ cells. Middle and bottom: Foxp3 expression by
CD4+ cells. Numbers depict % of gated cells. Representative of three experiments. (B and C) Summary data on fraction and number of cells. Mean ± SD (nR 4).
(D) Immunofluorescence microscopy of muscle sections 7 days after injury. The same section without (top) or with (bottom) DAPI. Arrows show Tregs in close
contact with regenerating myofibers. Original magnification 3400.
(E) As in (B), but after cryoinjury.
See also Figure S1.injury. We address the impact of this population on muscle
repair, its implication in genetically determined muscle aber-
rancies, and the potential therapeutic effects of modulating this
population and one of the proregenerative factors it produces.
RESULTS
Treg Cells Accumulate in Acutely Injured Skeletal
Muscle Just as the Myeloid Cell Infiltrate Switches from
a Proinflammatory to a Proregenerative Phenotype
Intramuscular (i.m.) administration of cardiotoxin (Ctx), which
rapidly induces myofiber necrosis, provides a convenient andwell-studiedmodel of tissue repair after acute injury. We injected
the tibialis anterior (TA), gastrocnemius, and quadricepsmuscles
of C57Bl/6 (B6) mice with Ctx and analyzed the resulting cellular
infiltrate various times later; control cells isolated from the unin-
jured contralateral muscles or the spleen were evaluated in
parallel. As anticipated (Arnold et al., 2007), there was a rapid
increase in CD11b+Gr1 myeloid mononuclear cells beginning
before day 1, initially a proinflammatory Ly6chi population but
switching to an anti-inflammatory Ly6clo population by day 4
(Figure 1A, top). Around this time, Treg cells began to accumu-
late in the injured muscle, their frequency within the CD4+
T cell compartment gradually increasing to 50% by 14 daysCell 155, 1282–1295, December 5, 2013 ª2013 Elsevier Inc. 1283
after Ctx injection and remaining at that level until at least day 30
(Figures 1A, middle, and 1B). Numbers of Treg and conventional
CD4+ T (Tconv) cells both peaked at day 4 after injury (Figure 1C),
mirroring the total number of CD45+ cells and T cells in the
infiltrate (Figure S1 available online). However, while Tconv cell
numbers had dropped to levels characteristic of uninjured
muscle by 28 days after Ctx injection, the number of Treg cells
remained elevated by 8-fold (1.05 ± 0.38 3 104 versus 0.13 ±
0.063 104 cells/gmuscle; p = 0.01; Figure 1C). Staining of frozen
sections with a fluorescently tagged anti-Foxp3 monoclonal
antibody (mAb) revealed Foxp3+ cells both in heavily infiltrated
(probably necrotic) areas and in regions between regenerating
fibers (recognizable as centrally nucleated, dystrophin-positive
cells) (Figure 1D). An analogous accumulation of Treg cells was
observed in a cryoinjury model (Figure 1E).
The Transcriptome of Muscle Treg Cells Is Distinct from
that of Other Treg Populations, Especially Those
Located in Lymphoid Organs
Four or 14 days after i.m. Ctx injection, we isolated Treg and
Tconv cells from muscles and lymphoid organs and performed
microarray-based gene-expression profiling. (Note that inade-
quate numbers precluded a comparison with analogous pop-
ulations from uninjured muscles.) According to both simple
comparison plots (Figure 2A) and principal components analysis
(PCA) (Figure 2B), the transcriptome of muscle Treg cells differed
from that of their spleen or lymph node counterparts much more
than the latter two did from each other. Muscle Tregs were most
like Treg cells located in adipose tissue (Figure 2B) but were still
readily distinguishable; a few hundred transcripts up- or downre-
gulated >2-fold in one vis-a`-vis the other. The similarity to
another Treg population residing in nonlymphoid tissue, and
dissimilarity to lymphoid-organ Treg cells, did not simply reflect
a higher activation state in tissues, because few of the distin-
guishing transcripts were members of a previously determined
Treg activation signature (Hill et al., 2007) (Figure 2C). Neither
did it reflect a universal ‘‘inflammation signature,’’ since themus-
cle Treg transcriptome was distinguishable from those of Tregs
at several inflamed sites (Figure S2). While exhibiting a distinct
gene-expression profile, muscle Treg cells are clearly ‘‘Treg,’’
showing the anticipated pattern of expression of 91% of the
canonical Treg signature (Hill et al., 2007); in particular, elevated
levels of diagnostic transcripts such as those encoding Foxp3,
CD25, and CTLA-4 (Figure 2D).
A fold-change/fold-change (FC/FC) plot afforded a more
detailed look at the muscle Treg transcriptome, revealing a set
of genes (highlighted in orange) that distinguish muscle Treg
from spleen Treg cells and spleen or muscle Tconv cells, and
another set (in gray) overexpressed by the two muscle popula-
tions vis-a`-vis their two spleen counterparts (Figure 2E; Table
S1). The first group includes loci encoding an anti-inflammatory
cytokine (interleukin [IL]-10), chemokine receptors (e.g., CCR1),
and two well-known growth factors (platelet-derived growth
factor [PDGF] and Amphiregulin [Areg]] (Pastore et al., 2008).
Loci upregulated in both Treg and Tconv cells from injured mus-
cle include those encoding KLRG1, an activation marker; CCR2,
important for the recruitment of various leukocyte populations to
injured muscle (Warren et al., 2005); and ST2 (encoded by Il1rl1),1284 Cell 155, 1282–1295, December 5, 2013 ª2013 Elsevier Inc.which is the receptor for the ‘‘alarmin’’ IL-33 (Schmitz et al.,
2005). A third group of genes (in pink) was repressed in muscle
Treg (and to varying degrees Tconv) cells; notably, those encod-
ing certain chemokine receptors (CXCR5 and CCR7) and several
proteins implicated in the Wnt signaling pathway (TCF7, LEF1,
SATB1).
We selected several of the genes upregulated in muscle Treg
cells and confirmed their induced expression at the protein level
by flow cytometry (Figure 2F). Such an analysis also revealed
muscle Tregs to be high-level expressors of Helios and Neuropi-
lin (Figure 2G) and were therefore likely to be Treg cells exported
as such from the thymus.
Treg Cells in Injured Muscle Are Clonally Expanded and
Display a Unique Repertoire of TCRs
The rapid accumulation of Treg cells at the injury site could
reflect their influx, proliferation, or some combination of the
two. Four days after Ctx injection, almost all muscle Treg cells
stained for Ki67 (Figure 3A), which is expressed in all stages of
the cell cycle except for the resting, G0, phase. EdU (5-ethynyl-
20-deoxyuridine), incorporated by cells in S phase, was detected
in 20%ofmuscle Tregs after 24 hr of labeling (Figure 3B). Amuch
lower fraction of splenic Treg cells was proliferating according to
both staining criteria. The muscle Tconv population also
exhibited an increased frequency of Ki67+ and EdU+ cells
compared with the spleen Tconv subset, although the values
remained significantly lower than those observed for muscle
Treg cells (Figures 3A and 3B).
To assess clonality of the Treg population expanding in acutely
injured skeletal muscle, we studied TCR repertoires by
sequencing the complementarity-determining region (CDR) 3
of the TCR a and TCR b chains of individually sorted cells.
Already at day 2 after injury, and continuing out at least until
day 8, a substantial proportion (20%–40%) of muscle Treg cells
were clonally expanded (Figures 3C and 3D; Table S2). This
sequence profile contrasted starkly with that of splenic Treg
cells, for which there was not one repeat sequence in the 692
sampled. As expected from the Ki67 and EdU stainings, we
also found clonal expansion of muscle Tconv cells (Figure 3D;
Table S2). However, there was not a single example of TCR-
sequence sharing between muscle Treg and Tconv cells.
In the muscle Treg data sets, there was a striking case of a
repeatedly detected TCR: identical paired CDR3 a and b (and
corresponding nucleotide) sequences picked up in multiple
mice in completely independent experiments (Figure 3E). Inter-
estingly, there were a few Treg cells (from multiple individuals)
that had the same TCR b chain paired with an a chain whose
CDR3 was modified only conservatively (AV/VL). These repeat
sequences were found in mice 2 or 4, but not 8, days postinjury.
They never showed up in the bulk spleen Treg or muscle Tconv
cell pools.
Ablation of Treg Cells Compromises Muscle Repair
According to Multiple Criteria
Having uncovered a unique population of Treg cells in the infil-
trates of skeletal muscle undergoing repair in response to acute
injury, we asked whether they play a role in muscle regeneration.
We punctually ablated Treg cells at the time of muscle injury,
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Figure 2. A Unique Population
(A–E) Gene-expression analyses on cells 14 days after Ctx injury. (A) Comparison plots of normalized expression values. Numbers indicate the number of genes
whose expression differed by more than 2-fold. (B) PCA analysis comparing muscle Tregs 4 or 14 days after Ctx injury with other Treg populations. Each dot
represents themean of three independent experiments. (C) Top: volcano plot comparing gene expression of muscle versus spleen Tregs. Bottom: same plot after
subtraction of the Treg activation signature (Hill et al., 2007). Numbers represent the number of differentially expressed genes (>2-fold). (D) Volcano plots
comparing gene expression of Treg versus Tconv cells. Treg signature genes (Hill et al., 2007) are highlighted in red (induced) or blue (repressed). Numbers
represent the number of genes from each signature expressed by each population. (E) Fold-change differences in gene expression between Treg and Tconv cells
from muscle and spleen. Differentially expressed genes are highlighted in orange, gray, or pink.
(F and G) Cytofluorometric analyses of surface and intracellular markers. Histograms depict expression by Foxp3+ T cells from muscle (red) or spleen (black).
Gray: isotype control.
See also Figure S2 and Table S1.exploiting a mouse line wherein the diphtheria toxin receptor
(DTR) is expressed under the control of Foxp3 regulatory
elements (Kim et al., 2007). B6.Foxp3-DTR+ and B6.Foxp3-
DTR littermates (hereafter referred to as DTR+ and DTR,
respectively) were given DT intraperitoneally (i.p.) starting from
the time of im Ctx injection and were analyzed 1 week later, a
time chosen to avoid the multiorgan autoimmunity provoked
by long-term ablation of Treg cells (Kim et al., 2007). This proto-
col resulted in effective depletion of Tregs in the injured muscleof the DTR+ mice (Figure 4A, top) as well as in the lymphoid
organs (Figure 4A, bottom).
According to multiple criteria, the loss of Treg cells had
profound effects on the muscle repair process. First, the size
of the cellular infiltrate was increased in the absence of Treg
cells, assessed either as numbers of total CD45+ cells or as
the fraction of T cells (Figure S3A). In addition, the myeloid cell
compartment failed to undergo the expected switch from a pri-
marily proinflammatory, Ly6chi to a primarily anti-inflammatory,Cell 155, 1282–1295, December 5, 2013 ª2013 Elsevier Inc. 1285
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Figure 3. Clonal Expansion of the Treg Population at the Injury Site
(A and B) Ki67 expression (A) and EdU uptake (B) 4 days after Ctx-induced injury. Left: representative dot plots of cells. Numbers refer to%marker+ Treg or Tconv
cells. Right: summary plots. n = 5; **p < 0.01; ***p < 0.001.
(C) TCR CDR3 a and CDR3 b sequences for individual cells. Each pie chart represents a single mouse. n, number of analyzed sequences per mouse. Total
frequency of expanded clones shown at the top right.
(D) Summary of clonal TCR frequencies over time. Open circles correspond to mice analyzed later in independent experiments for Figure 7. Mean ± SD (nR 3).
(E) Identical paired CDR3-a and b sequences found in multiple individuals in independent experiments. Two CDR3 a sequences from independent mice bear two
conserved substitutions.
See also Table S2.Ly6clo phenotype (Figures 4B and S3A). Similar results were
obtained when DT was administered i.m., which specifically
depleted muscle Treg cells without detectably affecting their
counterparts in lymphoid organs (data not shown).
DTR-mediated in vivo ablation of a designated cell population
is known to be apoptotic and noninflammatory (Bennett and
Clausen, 2007). Nonetheless, as detailed in Figure S3B and its
legend, we performed an experiment on female heterozygous
DTR-positive mice to show that the more inflammatory flavor
of the infiltrate in mice lacking Treg cells was not a simple artifact
related to their death, but rather a reflection of their functional
absence.
Second, Treg cell ablation altered the histological features of
skeletal muscle repair (Figure 4C). Although centrally nucleated1286 Cell 155, 1282–1295, December 5, 2013 ª2013 Elsevier Inc.fibers indicative of regeneration could be detected in muscle
from both DTR and DTR+ mice, in the latter case, the tissue
structure showed a disorganized pattern, with several foci of
inflammation. As anticipated, no infiltrate or regenerating fibers
were found in the contralateral, uninjured muscles from mice
that did or did not have Treg cells (data not shown). One of
the later consequences of impaired muscle repair is fibrosis:
Gomori’s Trichrome staining showed Treg-less mice to have a
substantial accumulation of collagen in the injured muscle
compared with their Treg-positive littermates (Figure 4D). To
provide a more quantitative view, we returned to the cryo-injury
model, wherein the area of injury is clearly delimited. Global
examination confirmed the impaired reparative capacity in
Treg depleted mice; a quantitative evaluation indicated that the
number of centrally nucleated fibers was significantly lower in
Treg-depleted than in normal muscles, with some muscles
from DTR+ mice showing an almost complete absence of regen-
erative fibers (Figure 4E).
Third, the absence of Treg cells during muscle repair had an
impact onmuscle progenitor cells. Satellite cells are the predom-
inant, if not sole, source of regenerated muscle fibers after acute
injury (Tabebordbar et al., 2013). Satellite cells were isolated
from uninjured or Ctx-injured muscle of DT-treated DTR+ or
DTR mice by double-sorting CD45Sca-1Mac-1CXCR4+
b1-integrin+ myofiber-associated cells (Cerletti et al., 2008),
and their functionality was evaluated in clonal myogenesis
assays, as described in (Cerletti et al., 2012) (Figure 4F). Injury
substantially enhanced the fraction of satellite cells from DTR
mice that formed myogenic colonies; in contrast, there was far
less (not significant) injury-induced enhancement of myogenic
activity in mice lacking Treg cells.
Fourth, to obtain a broad, unbiased view of the repair path-
ways impacted by Treg ablation, we performed microarray-
based gene-expression profiling of whole, unfractionated
muscle tissue. In general, for standard (DTR) mice, sets of
genes were up- or downregulated early after injury (day 4),
and expression values began to return to normal as the wound
started to repair (day 8). The pattern of expression of many
genes was altered in the absence of Treg cells (DTR+) (Figures
4G, S3C, and S3D; Table S3), with three main clusters meriting
discussion: One group (highlighted in blue) is composed of
genes encoding proteins with important roles in muscle homeo-
stasis and function. These loci were highly expressed in unin-
jured muscle and were downregulated in both DTR and
DTR+ mice at day 4 after injury owing to the loss of mature mus-
cle fibers. In muscle of DTR mice, transcript levels began to
increase by day 8, as efficient repair ensued; however, in mus-
cle of DTR+ individuals, expression of these loci remained low
or in decline at day 8, confirming that the lack of Treg cells
compromised the recovery of muscle homeostasis after injury.
Another group (green) includes genes encoding proteins neces-
sary for muscle repair, like MyoG (myogenin) and Mmp12
(metallopeptidase-12), but also some factors related to the
immune response, in particular a number of chemokines and
chemokine receptors, some cytokine receptors, and C1qa, a
complement cascade trigger. In DTR mice, expression of
these loci was increased at day 4 but rapidly crashed there-
after, approaching the level in muscles of uninjured mice by
day 8. However, in DTR+ mice, this drop did not occur or was
greatly attenuated, again suggesting an ineffective and pro-
longed repair process, especially given the recent report that
C1qa and related molecules strongly inhibit muscle regenera-
tion (Naito et al., 2012). Strikingly, the expression pattern of
C1qa in injured muscle was mirrored by that of C1qb, C1qc,
C1r, C1rb, and C1s as well (Figure S3D). A final group (high-
lighted in red) is composed of two types of genes: those encod-
ing molecules characteristic of immune cells (e.g., CD8a, CD2)
and those specifying matrix proteins (e.g., Col6a5). Expression
of these loci was upregulated at day 4 and even more so at day
8 only in mice lacking Treg cells, reflecting their more pro-
nounced muscle infiltrate (Figure S3A) and fibrotic collagen
deposition. Microarray expression values for multiple examplesof each of these groups are plotted in Figures 4G and S3D, and
confirmatory quantitative PCR data for representative group
members are presented in Figure S3C. Monitoring expression
of these groups of genes should provide a novel and conve-
nient means to quantitatively assess the fidelity of events
underlying muscle repair.
As illustrated in Figures S3E and S3F, Rag-deficient mice,
lacking all lymphoid cells, showed more pronounced fibrosis
than did wild-type individuals, measured histologically or by
quantifying collagen transcripts. However, fibrosis was milder
and repair progressed more effectively in Rag-1-deficient mice
than in Treg-depleted mice.
In summary, evaluations of myeloid cell numbers and pheno-
type, histology, satellite cell function, and global patterns of
gene expression all argue that Treg cells are important for
effective repair after acute injury of skeletal muscle. These
observations raise the question of whether Treg cells impact
muscle aberrancies in other contexts.
An Analogous Treg Population Is Expanded in the
Damaged Muscles of Mouse Models of Muscular
Dystrophy
In muscular dystrophies, chronic destruction of muscle fibers is
accompanied by an inflammatory response and, in general, a
permanent infiltrate. Mdx mice carry a nonsense mutation in
the Dmd gene (encoding Dystrophin), which is analogous to
those found in DMD patients. In the mouse model, as in the
human disease, the most affected sites are the diaphragm and
hindlimb muscles. We analyzed the muscle infiltrate in 4-week-
old mdx mice, when the disease is in its acute phase, and at
12 weeks, during the chronic phase. In both muscle groups at
both ages, the fraction of Treg cells was significantly elevated
vis-a`-vis the frequency in corresponding muscles of wild-type
mice; such an increase was not observed in the spleen (Fig-
ure 5A). Likewise, the muscle infiltrates of Dysferlin-deficient
mice, which model limb-girdle muscular dystrophy type 2B or
Miyoshi myopathy (Tabebordbar et al., 2013), were enriched in
Treg cells, while their frequency in the spleen was the same as
in wild-type controls (Figure S4A).
That the Treg cells accumulating in dystrophic muscle of mdx
mice were bona fide muscle Tregs was indicated by their
elevated expression of phenotypic markers such as Areg, ST2,
KLRG1, and TIM-3 (Figure S4B). (Unfortunately, we could not
isolate adequate numbers of Treg cells from the muscles of
mdx mice to perform a transcriptome analysis [<500 Tregs/
mouse].) In addition, the Treg populations of mdx muscle ex-
hibited clonal expansions, with an even greater fraction of the
population derived from expanded clones and an even larger
average clone size than found for Ctx-injured muscles of wild-
type mice (compare Figures 5B and 3C; also see Table S2).
Next, we performed loss- and gain-of-function studies to
evaluate the role(s) of muscle Treg cells in mdx mice. It was
not feasible to use the B6.Foxp3-DTR system for the loss-of-
function experiments because both the Foxp3 and Dmd genes
are located on the X chromosome. Therefore, we manipulated
levels of Treg cells by treatment with an anti-CD25 mAb, an
approach that has been exploited by a number of investigators
to study Treg function (e.g., Suvas et al., 2004). AdministrationCell 155, 1282–1295, December 5, 2013 ª2013 Elsevier Inc. 1287
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of anti-CD25 to 2.5-week-old mdx mice did not reduce overall
Treg cell numbers, whether in skeletal muscle or the spleen,
but did largely eliminate the fraction expressing high levels of
CD25 (Figure 5C). This changewas accompanied by a significant
increase in serum levels of creatine kinase (CK), an enzyme
released into the blood upon muscle damage and a standard
indicator of muscle damage in dystrophic mouse models.
For the gain-of-function experiments, we made use of the
published observation that complexes of recombinant IL-2
and a particular anti-IL-2 mAb (clone JES6-1A12) can prefer-
entially expand Treg populations after injection into mice
(Boyman et al., 2006). A few days before the peak of acute dis-
ease (3 weeks of age), we administered IL-2:JES6-1A12 com-
plexes to mdx mice for 6 consecutive days. As anticipated,
this treatment induced a significant increase in the frequency
of Treg cells in the muscle, which, in addition, displayed higher
levels of CD25 (Figure 5D, bottom). An elevated fraction of
Treg cells was also observed in the spleen immediately after
the cessation of treatment (14% and 42% of CD4+ cells in
control and complex-administered mice, respectively; data
not shown), but this increase was not sustained (Figure 5D,
top). Accompanying the boost in Treg cells was a significant
reduction in serum CK levels (Figure 5D), indicative of less
muscle damage.
To gain further insight into the effects of Treg depletion in
dystrophic muscle, we performed whole-muscle transcriptional
analyses, comparing muscles from control and Treg-depleted
mdx mice (Figure S4C). The genes encoding osteopontin
(Spp1; 2.1-fold) and connective-tissue growth factor (Ctgf;
1.8-fold), both of which promote skeletal muscle fibrosis and
mdx pathology (Morales et al., 2011; Vetrone et al., 2009),
were upregulated in the absence of Tregs. More generally, it
became clear that, on the one hand, Treg cells were protecting
mdx mice from muscle pathology, as their ablation downregu-
lated most of the aforementioned gene set related to muscle
homeostasis and function (highly expressed in healthy wild-
type muscle), but that, on the other hand, Treg cells were pro-
moting muscle repair because their removal upregulated
expression of the set of genes whose inhibition was normally
an accompaniment to healthy repair (Figure S4C). (In addition,
there was a striking correspondence between the genes
induced in muscle from Treg-ablated mdx mice and those
repressed in muscle from amphiregulin-treated mice [dis-
cussed below].)Figure 4. Treg Ablation Impairs Muscle Regeneration after Wounding
Eight-week-old Foxp3DTR+ or DTR littermates were injured with Ctx and trea
(A and B) Flow cytometry of Treg and myeloid-lineage population, 7 days postinju
refer to % Ly6c/lo or Ly6chi of CD11b+ cells.
(C) Hematoxylin and eosin (H&E) staining of muscle sections 7 days after Ctx inju
(D) Left: fibrosis detection by Gomori trichrome staining of muscle sections 13 day
and seven DTR mice. Original magnification 3200. Right: summary quantificati
(E) Left: H&E staining of muscle sections 7 days after cryoinjury. Original magnifi
samples. Right: quantification of regenerative fibers per mm2 of injured area. ***p
(F) Clonal myogenesis assays of satellite cells from uninjured or day 4 Ctx-injure
Summary of six clonal assays *p < 0.05; **p < 0.01.
(G) Left: FC/FC plot of gene expression values in muscle 4 versus 8 days after C
different colors are sets of genes described in the text. Right, representative exa
See also Figure S3 and Table S3.Amphiregulin, a Growth Factor Overexpressed by
Muscle Treg Cells, Enhances Muscle Regeneration
The regulation that muscle Treg cells imposed on infiltrating
myeloid cells was probably responsible, at least in part, for the
impaired muscle repair observed in the absence of Tregs. How-
ever, analogous to the situation with VAT (Feuerer et al., 2009;
Cipolletta et al., 2012), it is likely that other mechanisms also
play a role, including a direct effect of muscle Tregs on muscle
progenitors, nascent myofibers, or other nonhematopoietic cell
types within muscle. Among the transcripts preferentially ex-
pressed by muscle Tregs vis-a`-vis lymphoid-organ Tregs, Areg
stood out as encoding a candidate factor capable of directly
impacting muscle regeneration. Areg belongs to the epithelial
growth factor (EGF) family and signals through the EGF receptor
(EGFR) system (Shoyab et al., 1989). EGFR is expressed by a
variety of cells, including muscle satellite cells and a myoblast
cell line, in which it appears to have antiapoptotic/survival func-
tions (Golding et al., 2007; Horikawa et al., 1999). Examination
of the ImmGen database (http://www.immgen.org) indicated
that most hematopoietic cell-types express no or only low levels
of Areg transcripts (Figure 6A). Nor is Areg expressed at signifi-
cant levels in the nonhematopoietic cell-types examined by Imm-
Gen (Figure S5A). In addition, the base-line levels of Areg
transcripts in injuredoruninjuredwhole-muscle samples,wherein
muscle-lineage cells were in great preponderance, argues that
muscle cells do not make significant Areg in this context either
(Figure S5A). However, Areg transcripts were readily detectable
in a few Treg populations. They were found at high levels in
muscle and adipose-tissue Treg cells, although hardly, if at all,
in lymphoid-organ Tregs. Substantial expression of Areg protein
in muscle Tregs, but only limited expression by their splenic
counterparts, was confirmed by flow cytometry (Figure 6B). The
fraction ofmuscle Treg cells expressing Areg protein began to in-
crease at day 4 and peaked at day 7 after Ctx injury (Figure S5B).
If Areg is important for the proregenerative function of muscle
Treg cells, then treatment of Treg-ablated mice with this growth
factor should ameliorate their deficit in muscle repair subsequent
to acute injury. To test this notion, we administered Areg to Ctx-
injected, DT-treated DTR+ mice according to the protocol
illustrated in Figure 6C, and evaluated gene-expression profiles
of repairing muscles at days 4 and 8 after injury. (Note that the
initial Areg injection was done i.m., promoting the muscle spec-
ificity of its effects.) Transcriptome changes were evaluated in
terms of the three gene clusters defined in Figure 4G andted with DT to induce Treg depletion.
ry. Numbers in (A) refer to % CD4+ T cells that are Foxp3+, and numbers in (B)
ry. Representative of at least three experiments. Original magnification 3100.
s after injury. Collagen stained in blue. Representative examples of seven DTR+
on.
cation 325 (left) and 3100 (middle and right). Representative examples of six
< 0.001.
d muscles. Percent of wells seeded that showed a myogenic colony at day 5.
tx-induced injury in mice without (DTR+) or with (DTR) Tregs. Highlighted in
mples of genes in each highlighted set.
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Figure 5. Treg Cells Are Enriched in Muscles of Dystrophic Mice and Impact Muscle Damage
(A) Frequency of Foxp3+ cells for mdx and control C57Bl/10 mice. Left: representative dot plots. Right: summary data. n = 5; **p < 0.01; ***p < 0.001.
(B) Treg clonal expansion in mdx muscle measured as described in the legend to Figure 3C.
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See also Figure S4 and Table S2.
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detailed above. Expression of all three gene groups was largely
normalized in Areg-treated Treg-less mice: vis-a`-vis buffer-only
controls: ‘‘muscle homeostasis/function’’ genes were upregu-
lated; muscle ‘‘repair/regeneration’’ loci were repressed as
required for effective repair; and inflammatory transcripts and
collagens were also downregulated (Figure 6C). These results
were confirmed in representative RT-PCR assays (Figure S5C).
We also tested whether administration of Areg was effective in
a contextwhere Tregswerepresent as normal (DTR orB6mice).
Under these conditions, Areg had a strong and rapid impact on
the ‘‘muscle homeostasis/function’’ and ‘‘repair/regeneration’’
gene groups but no significant effect on the ‘‘immune response/
inflammation’’ groups, at least according to volcano-plot visuali-
zation and representative RT-PCR assays (Figures 6D and S5D).
More detailed analysis showed that Areg dampened expression
of several loci encoding proteins related to fibrosis (e.g., a battery
of collagens, Acta2, Adam12), and enhanced expression of loci
encoding molecules highly represented in healthy muscle, like
Pfkfb1 and 3 and Myl2 (Figure 6E).
Because our previous results indicated that Treg cells can in-
fluence the efficacy of myogenic colony formation by muscle
precursor cells (Figure 4F), and given the high-level expression
of Egfr by the satellite cells employed in our assays (and, paren-
thetically, minimal expression by muscle Treg cells; Figure S5E),
we investigated whether Areg might have a direct effect on sat-
ellite cells. Addition of Areg to myogenic assays significantly
augmented the colony-forming efficiency of satellite cells from
unmanipulated B6 mice (Figure 6F). In addition, Areg enhanced
myogenic differentiation in bulk cultures of satellite cells, as indi-
cated both by increased levels of transcripts encoding myosin
heavy chain (MyHC) (Figure 6G, left) and by increased numbers
of cells that stained for MyHC protein (Figure 6G, center). In
contrast, there was no apparent difference in proliferation in sat-
ellite cell cultures with or without Areg (Figure 6G, right).
Since Areg was expressed by a small fraction of splenic Treg
cells in addition to a considerable proportion of muscle Tregs
(Figure 6B), we wondered whether the two Areg+ populations
might somehow be related. As opposed to the lack of clonality
characteristic of bulk splenic Treg cells (Figure 3C), 5% of
the splenic Areg+ subset was clonally expanded (Figure 7A).
There was, indeed, some degree of overlap between the CDR3
a and CDR3 b sequences of splenic Areg+ Treg cells and those
of muscle Tregs (independent of their expression of Areg)
(Figure 7B). The muscle Areg+ and Areg subsets showed no
difference in their extent of clonal expansion (Figure 7C) or in
their representation of the oft-repeated TCR sequence illustrated
in Figure 3E (Table S2).
DISCUSSION
A Unique Population of Treg Cells that Accumulates in
Skeletal Muscle
There is growing appreciation that the Treg compartment is
heterogeneous, has multiple functions, and exerts influences
exceeding the boundaries of the immune system (Josefowicz
et al., 2012). Here, we have described a previously unrecognized
population of Treg cells that emerges in skeletal muscle sub-
jected to acute or chronic damage and have demonstratedthat these cells are important players in the muscle-repair
process.
Treg cells began to accumulate in injured muscle within days
after an insult. That this enrichment represents a conversion of
the Tconv to the Treg phenotype is unlikely given that essentially
all of the muscle Treg cells expressed Helios and Neuropilin,
considered to be markers of Treg cells exported as such from
the thymus, and that none of their TCRswere sharedwithmuscle
(or lymphoid-organ) Tconv cells. Rather, the elevated levels of
muscle Tregs appear to reflect population expansion: they
were proliferating in the muscle, substantially more so than in
the spleen, and constituted a number of clonally expanded
micropopulations. There might also be preferential recruitment
of muscle-type Tregs to injured muscle, perhaps driven by one
or more members of the constellation of chemokine receptors
up- or downregulated vis-a`-vis lymphoid-organ Tregs, certain
of which have been implicated in migration of diverse leukocyte
subsets to skeletal muscle (Warren et al., 2005). Interestingly, a
small population of Areg+ splenic Treg cells appeared to include
a muscle Treg constituent, evidenced by shared TCR se-
quences. But it is not clear at present whether the splenic popu-
lation seeds or arises from the Treg population accumulating in
injured muscle.
Several other elements of the muscle Treg transcriptome
distinguish it from that of lymphoid-organ Treg cells. Included
in the list of repressed genes is Satb1, which encodes a
chromatin organizer that inhibits Treg suppressive activity
(Beyer et al., 2011). The reduced numbers of Satb1 transcripts,
coupled with enhanced expression of transcripts encoding
other molecules linked to Treg suppressive function, like IL-
10, Gzmb, CTLA-4, and TIM-3 (Josefowicz et al., 2012),
support the idea that muscle Treg cells might be endowed
with especially strong suppressor activity. Moreover, muscle
Treg cells overexpressed certain genes whose products could
arm them to perform particularly effectively in the context of
regenerating muscle. Areg is a prime example. Interestingly, it
was recently reported that Areg might also impact Treg cells
directly and enhance their ability to suppress immune re-
sponses (Zaiss et al., 2013). However, expression of Egfr was
undetectable in Treg cells from lymphoid (spleen, lymph
node) or nonlymphoid (muscle, VAT) tissues in our microarray
studies.
In addition, the TCR repertoires of injured-muscle and
lymphoid-organ Treg cells were clearly distinct. There were
striking clonal expansions in the muscle Treg population and
one TCR a and TCR b chain pair was found over and over again
in different individuals despite Draconian measures to avoid
contamination. Interestingly, the small subset of Areg+ splenic
Tregs did share TCR sequences with muscle Treg cells, whether
Areg positive or negative. These findings raise the possibility that
a muscle antigen might be involved in recruiting Treg cells to the
site of injury and/or retaining them therein.
How Might Treg Cells Influence Muscle Repair?
Muscle repair subsequent to acute injury was impaired in the
absence of Treg cells, an influence no doubt exerted at several
levels. First, Tregs regulated the myeloid populations that infil-
trated the damaged tissue, appearing to contain their numbersCell 155, 1282–1295, December 5, 2013 ª2013 Elsevier Inc. 1291
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Figure 6. Areg Improves Muscle Repair after Injury
(A) Expression of Areg in ImmGen microarray data sets from hematopoietic-lineage cells. Mo, monocytes; MF, macrophages; DC, dendritic cells; GN,
granulocytes; MDSC, myeloid-derived suppressor cells; AU, arbitrary units.
(B) Expression of Areg 2 weeks after Ctx-induced injury. Numbers represent % Foxp3+ cells that are Areg+.
(C) Volcano plots of transcriptomes of whole muscle from injured DTR+ (Treg-less) mice treated or not treated with Areg. Left: experimental protocol. Right:
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(legend continued on next page)
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also Table S2.and to promote their switch from a pro- to an anti-inflammatory
phenotype. Both ‘‘flavors’’ of myeloid cell are important for
proper muscle repair, and any alteration in the tightly orches-
trated scenario wherein each accumulates and functions at the
site of injury can be detrimental (Tidball and Villalta, 2010). A
variety of intrinsic and extrinsic factors are responsible for their
phenotypic polarization; we propose that Treg cells represent
an additional layer of control.
Second, Treg cells also regulated coinfiltrating conventional
T cell populations. Upon Treg depletion, the total number and
frequency of T cells in the injured muscle was significantly
increased, andmany T cell-specific geneswere overrepresented
in whole-muscle microarrays of injured muscle from standard
versus Treg-less mice. Moreover, depletion of Treg cells in
Rag-deficient mice had a less severe influence onmuscle regen-
eration after acute injury than did ablation of Tregs alone,
suggesting that infiltrating Tconv cells (and/or CD8+ or B cells)
normally have a negative impact on muscle repair that is kept
in check by Treg cells. Yet, the effect of removing Treg cells
was not abrogated by eliminating the other lymphocyte classes,
indicating that Tregs can impact muscle regeneration indepen-
dently of either T or B cells.
Third, Treg cells impacted the activities of muscle-lineage
cells, specifically satellite cells. According to clonal myogenic
assays, satellite cells from Treg-deficient mice had decreased
colony-forming capacity, consistent with the reduced in vivo
regenerative potential of Treg-depleted muscle. Thus, Treg cells
can regulate the cells that are directly responsible for the repair
of injured muscle. In vitro experiments have shown that macro-
phages can directly influence muscle progenitors (Bosurgi
et al., 2011); it is possible, then, that Treg cells act on satellite(G) Induction of satellite cells differentiation by Areg. Satellite cells were bulk-cult
titered by quantitative PCR, represented as fold-change expression ofMyh2 relat
microscopy; differentiation index calculated as the mean ratio of MyHC-positive n
well. Data represent mean ± SD and four experiments. *p < 0.05; ***p < 0.0001.
See also Figure S5.cells indirectly, by modulation of the infiltrating myeloid popula-
tions. However, two of our results suggest a more direct effect:
(1) histological evidence that Treg cells were located in close
proximity to regenerating fibers (in addition to being present in
heavily infiltrated areas); and (2) the demonstration that muscle
Tregs expressed Areg and that this molecule enhanced satellite
cell differentiation in vitro and in vivo. Areg is an EGF family
member known to promote healing and regeneration of multiple
tissues, for example intestinal mucosa and lung epithelium
(Shao and Sheng, 2010; Monticelli et al., 2011). Most relevant
in the current context, previous studies have suggested
that Areg might act directly on muscle cells (Golding et al.,
2007; Andrechek et al., 2002). Together with these previous
studies, our results suggest that Areg may directly modulate
muscle repair.
Treg cells and their products are new players to consider in the
orchestrated series of events underlying muscle repair in both
acute and chronic contexts. Poor wound healing is a growing
problem, especially given its association with diabetes and
aging, both of which affect a large and increasing fraction of
the population. Moreover, adequate treatments for muscular
dystrophies remain elusive. Harnessing the power of Treg cells,
whether in cell- or molecule-based strategies, opens novel ther-
apeutic avenues.EXPERIMENTAL PROCEDURES
Mice and Their Manipulation
C57BL/6, C57BL/10ScSn, RAG1-deficient, and C57BL/10ScSn-Dmdmdxmice
were purchased from Jackson Laboratory. Foxp3-DTR, Foxp3-IRES-gfp, and
Dysferlin-deficient mice were obtained from A. Rudensky, V. Kuchroo, and R.ured in the presence of Areg or vehicle control for 12 days. Left: MyHC mRNA
ive to vehicle control. Center: MyHC protein quantified by immunofluorescence
uclei to the total nuclei per field of view. Right: sum of DAPI-positive nuclei per
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Bittner, respectively. All mice were bred in our specific-pathogen-free facilities
at Harvard Medical School. Protocols were approved by Harvard Medical
School’s Institutional Animal Care and Use Committee.
We injected anesthetized mice i.m. with 0.03 ml/muscle of Naja
mossambica mossambica cardiotoxin (0.03 mg/ml) (Sigma) in one or more
hindlimb muscles. Alternatively, TA muscles were directly exposed to dry ice
for 5 s.
A total of 1 mg of EdU was injected intravenously, and 24 hr later cells were
processed for detection by the Click-iT EdU kit (Molecular Probes).
Foxp3-DTR+ mice and Foxp3-DTR littermates were injected i.p. with
DT (Sigma), at 6 ng/g body weight, every other day for 6 days, starting at
the day of injury. Depletion of CD25+ cells was accomplished by i.p. injection
of 100 mg of anti-CD25 mAb (clone PC61) or rat IgG (Jackson
ImmunoResearch) at days 17 and 20 of age. Muscle infiltrate and serum
CK were analyzed 7 days after the last injection, the latter via the Creatine
Kinase-SL kit (Genzyme). For expansion of Tregs, we incubated 2.5 mg
of anti-mouse IL-2 mAb (JES6-1A12) and 0.25 mg of mouse IL-2 per mouse
for 20 min on ice followed by i.p. injection. Then 17-day-old mdx mice
were given daily injections for 6 days and were analyzed 10 days after the
last injection. Control mice were administered phosphate-buffered saline
(PBS).
Recombinant mouse Areg (R&D Systems) was administered i.m. (1 mg/
muscle) together with Ctx at day 0. Areg was then injected i.p. (7 mg/mouse)
every other day until the time of analysis.
Muscle Leukocytes and Manipulations of Them
Micewere perfusedwith PBS.Muscles were excised, cut up, and collagenase/
DNase digested, and leukocytes were isolated by standard procedures. For
RT-PCR analyses and single-cell TCR sequencing, published protocols
(Wong et al., 2007; Baker et al., 2002) were followed with some modifications
to the primer sets used. Raw sequencing files were filtered for sequence qual-
ity, processed in automated fashion, and parsed using IMGT/V-QUEST (Bro-
chet et al., 2008). See detailed protocols in the Extended Experimental
Procedures.
Microarray
Cells were double-sorted into TRIzol (Invitrogen). Whole-muscle tissue was
flash frozen in liquid nitrogen and homogenized in TRIzol. Data sets used
for comparison in the PCA were previously generated in our lab. All samples
were generated in duplicate or (usually) triplicate. Sample processing
and data analysis were performed as previously described (Cipolletta et al.,
2012).
Clonal Myogenesis and Myogenic Differentiation Assays
For the clonal assays, myofiber-associated cells were prepared from hind-limb
muscles as described (Cerletti et al., 2008). Satellite cells (CD45Sca-
1Mac-1CXCR4+b1-integrin+) were double-sorted individually into 96-well
plates and cultured for 5–7 days. Wells containing myogenic colonies were
scored as described in Extended Experimental Procedures.
For differentiation assays, 3,000 satellite cells were double-sorted onto 24-
well plates, cells were cultured ±1 ng/ml recombinant mouse Areg, and after
12 days the cultures were processed for RT-PCR or immunofluorescence
microscopy of myosin expression as described in the Extended Experimental
Procedures, which also details our method of scoring and calculation of the
differentiation index.
Statistical Analyses
Data were routinely presented as means ± SD. Significance was assessed by
the Student’s t test or ANOVA. A p value of < 0.05 was deemed statistically
significant.
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